Many groups reported that KLF4 acts as an anti-oncogene against various cancers including bladder [32, 33], colorectal [34, 35], gastric [36], pancreas [37], esophageal [38], lung [39], prostate [40], and hepatocellular carcinoma [41]. This evidence concerns the gene KLF4 and hepatocellular carcinoma.